Cancer Institute Clinical Trials - Gastrointestinal

Colorectal

#120549 NCT01765582
Title:
STEAM (SEQUENTIAL TRIPLET AND AVASTIN MAINTENANCE): FOLFOXIRI/BEVACIZUMAB REGIMENS (CONCURRENT AND SEQUENTIAL) VS. FOLFOX/BEVACIZUMAB IN FIRST-LINE METASTATIC COLORECTAL CANCER
Study Location:
Temple Main Campus
Indication
: Metastatic Colorectal Cancer

#100177 NCT01183780
Title: A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine (14T-MC-JVBB)
Study Location: Temple Main Campus

#90569 NCT00608361
Title: Dasatinib in Treating Patients with Metastatic or Unresctable Solid Tumor or Lymphoma
Study Location: Temple Main Campus


Print
Text Size
A
A
A